NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohns disease and ulcerative colitis[1][2].
Molecular Weight:
399.44
Purity:
98.11
CAS Number:
[2389235-01-0]
Formula:
C24H21N3O3
Target:
NOD-like Receptor (NLR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
